Xeris Pharmaceuticals | XERS - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Celltrion KRW 12.71B 237.27B 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Eli Lilly USD 2.93B 198M 2026-03
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 632K 2.33M 2025-06
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 267.3M 11.4M 2026-03
Pharma Mar EUR 15.31M 2M 2026-03
Qiagen NV USD 153.88M 10.77M 2025-12
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Tilray USD 24.85M 1.7M 2025-09
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03